NCT02844309 2026-02-11
BDH-WM02
Institute of Hematology & Blood Diseases Hospital, China
Phase 4 Completed
Clinical Trials
6 trialsNCT02858804 2026-02-11
BDH-MCL01
Institute of Hematology & Blood Diseases Hospital, China
Phase 4 Completed
NCT07321613 2026-01-07
Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients
Shanghai Zhongshan Hospital
Completed
NCT00769587 2025-09-22
Thalidomide in Treating Patients With Relapsed or Progressive Systemic Mastocytosis
Centre Hospitalier Universitaire, Amiens
Completed
NCT01998971 2025-04-25
A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma
Janssen Research & Development, LLC
Phase 1 Completed
NCT02541383 2025-04-13
Cassiopeia
Intergroupe Francophone du Myelome
Phase 3 Completed